These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19635960)

  • 1. Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.
    Allou N; Cambau E; Massias L; Chau F; Fantin B
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4292-7. PubMed ID: 19635960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.
    Kerrn MB; Frimodt-Møller N; Espersen F
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1002-9. PubMed ID: 12604534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil.
    Kiffer CR; Camargo EC; Shimakura SE; Ribeiro PJ; Bailey TC; Pignatari AC; Monteiro AM
    Int J Health Geogr; 2011 Feb; 10():17. PubMed ID: 21356088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection.
    Sadiq MW; Nielsen EI; Khachman D; Conil JM; Georges B; Houin G; Laffont CM; Karlsson MO; Friberg LE
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):69-79. PubMed ID: 27578330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal hypoglycemia with ciprofloxacin in a dialysis patient: A case report.
    Matoi A; Taguchi M; Nishi S
    Clin Case Rep; 2021 Apr; 9(4):1902-1904. PubMed ID: 33936612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and genetic characterization of fluoroquinolone resistance gene
    Chen Y; Liu L; Guo Y; Chu J; Wang B; Sui Y; Wei H; Hao H; Huang L; Cheng G
    Microbiol Spectr; 2024 Apr; 12(4):e0300023. PubMed ID: 38411972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A
    Babosan A; Skurnik D; Muggeo A; Pier GB; Baharoglu Z; Jové T; Ploy MC; Griveau S; Bedioui F; Vergnolle S; Moussalih S; de Champs C; Mazel D; Guillard T
    Elife; 2022 Jan; 11():. PubMed ID: 35037621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid Mediated
    Majewski P; Gutowska A; Smith DGE; Hauschild T; Majewska P; Hryszko T; Gizycka D; Kedra B; Kochanowicz J; Glowiński J; Drewnowska J; Swiecicka I; Sacha PT; Wieczorek P; Iwaniuk D; Sulewska A; Charkiewicz R; Makarewicz K; Zebrowska A; Czaban S; Radziwon P; Niklinski J; Tryniszewska EA
    Front Microbiol; 2021; 12():547020. PubMed ID: 34956105
    [No Abstract]   [Full Text] [Related]  

  • 9. Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period.
    Royer G; Darty MM; Clermont O; Condamine B; Laouenan C; Decousser JW; Vallenet D; Lefort A; de Lastours V; Denamur E;
    Genome Med; 2021 May; 13(1):77. PubMed ID: 33952335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 44 Vibrio anguillarum genomes reveals high genetic diversity.
    Hansen MJ; Kudirkiene E; Dalsgaard I
    PeerJ; 2020; 8():e10451. PubMed ID: 33344086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of Resistant Bacteria in Mallards Exposed to Subinhibitory Concentrations of Ciprofloxacin in Their Water Environment.
    Atterby C; Nykvist M; Lustig U; Andersson DI; Järhult JD; Sandegren L
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin Pharmacokinetics/Pharmacodynamics against Susceptible and Low-Level Resistant Escherichia coli Isolates in an Experimental Ascending Urinary Tract Infection Model in Mice.
    Jakobsen L; Lundberg CV; Frimodt-Møller N
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiota.
    Tepekule B; Abel Zur Wiesch P; Kouyos RD; Bonhoeffer S
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23106-23116. PubMed ID: 31666328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Immunocompetent Urinary Tract Infected Balb/C Mouse Model For the Study of Antibiotic Resistance Development Using
    Chockalingam A; Stewart S; Xu L; Gandhi A; Matta MK; Patel V; Sacks L; Rouse R
    Antibiotics (Basel); 2019 Sep; 8(4):. PubMed ID: 31569374
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lian X; Wang X; Liu X; Xia J; Fang L; Sun J; Liao X; Liu Y
    Front Cell Infect Microbiol; 2019; 9():242. PubMed ID: 31334135
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic screening for quinolone resistance in Escherichia coli.
    Dellgren L; Claesson C; Högdahl M; Forsberg J; Hanberger H; Nilsson LE; Hällgren A
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1765-1771. PubMed ID: 31214796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance mechanisms among third-generation cephalosporin resistant isolates of
    Markovska R; Stoeva T; Dimitrova D; Boyanova L; Stankova P; Mihova K; Mitov I
    Infect Drug Resist; 2019; 12():1445-1455. PubMed ID: 31213860
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of quinolone resistance genes among extended-spectrum β-lactamase (ESBL)-producing
    FarajzadehSheikh A; Veisi H; Shahin M; Getso M; Farahani A
    Trop Med Health; 2019; 47():19. PubMed ID: 30872947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
    Rodríguez-Baño J; Gutiérrez-Gutiérrez B; Machuca I; Pascual A
    Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29444952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Clinical Assessment of the Antimicrobial Activity of Finafloxacin Compared to Ciprofloxacin in Subsets of Microbiologically Characterized Isolates.
    Vente A; Bentley C; Lückermann M; Tambyah P; Dalhoff A
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.